Riding the Biotech Financing Rollercoaster

Ernst & Young’s latest industry report assesses the grim prospects THE ANNUAL BEYOND BORDERS: Global Biotechnology Report from Ernst &Young’s Global Biotechnology Center (GBC; Cambridge, MA) pulls together perspectives from around the world on how the industry is performing for […]

Read More

Fine-Tuning Specialty Distribution

Specialty pharmaceuticals are the fastest growing segment of drugs in healthcare in the United States. With projected US growth of 178% from 2003-2010, the dollar value of available specialty drugs will surpass that of generic prescription medications.[1] Sales of specialty […]

Read More